{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-409335","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2026-09-30T22:00:51+00:00","discovered_at":"2026-10-01T10:05:00.293503+00:00","generated_at":"2026-10-12T14:11:52.776137+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sagimet Biosciences prices $115M offering: 8.75M shares at $10, 2.75M pre-funded warrants for Phase 3 acne trial","bullets":["Offering: 8,750,010 shares at $10.00 and pre-funded warrants for 2,750,010 shares at $9.9999 (gross ~$115M); net proceeds ~$107.5M; close Oct 1, 2026.","Proceeds fund Phase 3 trial of denifanstat in acne, pre-launch activities, TVB-3567 through Phase 2 topline, topical FASN inhibitor program to IND, and general corporate purposes.","Pre-funded warrants exercisable immediately at $0.0001/share; 4.99% beneficial ownership cap (9.99% at purchaser election), adjustable to 19.99% with 61 days' notice.","Leerink, TD Securities, Guggenheim and Oppenheimer are joint book-running managers; Canaccord Genuity, H.C. Wainwright, JonesTrading and Clear Street are co-lead managers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-409335","json":"https://secwatch.observer/filing/0001193125-26-409335.json","markdown":"https://secwatch.observer/filing/0001193125-26-409335.md","text":"https://secwatch.observer/filing/0001193125-26-409335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526409335/0001193125-26-409335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000119312526409335/d136610d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:11:52.776137+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}